Inovio Researchers Successfully Demonstrate RNA Drug Delivery via Electroporation

by lowes1 on February 22, 2012

http://photos.prnewswire.com/prnc/20120131/LA44118LOGOBLUE BELL, Pa., Feb. 22, 2012 /PRNewswire/ — Inovio Pharmaceuticals, Inc. (NYSE Amex: INO) announced today that its next generation surface skin electroporation technology was successfully used to significantly enhance the delivery of small interfering RNA (siRNA) molecules to skin in…


View full post on PR Newswire: Medical Pharmaceuticals

Leave a Comment

Previous post:

Next post: